Authors:
Saylors, RL
Stine, KC
Sullivan, J
Kepner, JL
Wall, DA
Bernstein, ML
Harris, MB
Hayashi, R
Vietti, TJ
Citation: Rl. Saylors et al., Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: A pediatric oncology group phase II study, J CL ONCOL, 19(15), 2001, pp. 3463-3469
Authors:
McMasters, RA
Wilbert, TN
Jones, KE
Pitlyk, K
Saylors, RL
Moyer, MP
Chambers, TC
Drake, RR
Citation: Ra. Mcmasters et al., Two-drug combinations that increase apoptosis and modulate Bak and Bcl-X-Lexpression in human colon tumor cell lines transduced with herpes simplex virus thymidine kinase, CANC GENE T, 7(4), 2000, pp. 563-573
Authors:
O'Brien, CA
Gubrij, I
Lin, SC
Saylors, RL
Manolagas, SC
Citation: Ca. O'Brien et al., STAT3 activation in stromal osteoblastic cells is required for induction of the receptor activator of NF-kappa B ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D-3 or parathyroid hormone, J BIOL CHEM, 274(27), 1999, pp. 19301-19308